T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Dime Commercial Bancshares
DCOM
$1.82B
| $83.6M | 0.01% |
2,387,662
-4,080
| -0.2% | -$142K |
|
702
Heritage Financial
HFWA
$1.23B
| $83.5M | 0.01% |
2,710,761
+151,716
| +6% | +$4.67M |
|
703
RE/MAX Holdings
RMAX
$265M
| $83M | 0.01% |
1,710,562
-658,080
| -28% | -$37.6M |
|
704
Pacira BioSciences
PCRX
$924M
| $82.9M | 0.01% |
1,817,066
+27,014
| +2% | +$1.07M |
|
705
Mueller Water Products
MWA
$3.98B
| $82.4M | 0.01% |
6,573,834
-77,103
| -1% | -$951K |
|
706
PennyMac Financial
PFSI
$4.13B
| $82M | 0.01% |
3,668,633
+196,860
| +6% | +$3.88M |
|
707
Grupo Aval
AVAL
$6.41B
| $82M | 0.01% |
9,645,299
+214,900
| +2% | +$1.84M |
|
|
CA
708
DELISTED
CA, Inc.
CA
| $81.5M | 0.01% |
2,447,477
+89,570
| +4% | +$2.97M |
|
709
Truist Financial
TFC
$64.7B
| $81M | 0.01% |
1,629,621
-68,669
| -4% | -$3.31M |
|
710
XPO
XPO
$24.7B
| $80.9M | 0.01% |
2,553,439
-138,249
| -5% | -$3.53M |
|
711
WSFS Financial
WSFS
$4.17B
| $80.7M | 0.01% |
1,685,896
+3,805
| +0.2% | +$188K |
|
|
XIFR
712
XPLR Infrastructure LP
XIFR
$1.09B
| $80.6M | 0.01% |
1,869,166
-24,550
| -1% | -$987K |
|
713
NorthWestern Energy
NWE
$4.4B
| $79.3M | 0.01% |
1,328,409
-40,840
| -3% | -$2.46M |
|
714
Saia
SAIA
$10.1B
| $79M | 0.01% |
1,116,995
-98,710
| -8% | -$6.33M |
|
715
Portland General Electric
POR
$5.92B
| $78.8M | 0.01% |
1,729,568
-738,492
| -30% | -$35M |
|
716
Ovintiv
OVV
$17.2B
| $78.5M | 0.01% |
1,177,448
-1,419,989
| -55% | -$83.8M |
|
|
CATM
717
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $78.4M | 0.01% |
4,231,737
+1,468,944
| +53% | +$29.4M |
|
|
ZNGA
718
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $78.1M | 0.01% |
19,535,805
+1,873,324
| +11% | +$7.3M |
|
719
Papa John's
PZZA
$804M
| $77.5M | 0.01% |
1,381,423
+5,530
| +0.4% | +$344K |
|
720
Clearwater Paper
CLW
$354M
| $77.4M | 0.01% |
1,705,839
-56,142
| -3% | -$2.55M |
|
|
AEGN
721
DELISTED
Aegion Corp
AEGN
| $77.2M | 0.01% |
3,034,238
+220,648
| +8% | +$5.54M |
|
722
Colliers International
CIGI
$5.41B
| $76.7M | 0.01% |
1,271,165
+336,515
| +36% | +$19.4M |
|
|
AAAP
723
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $76.7M | 0.01% |
939,360
-1,446,585
| -61% | -$112M |
|
724
AXIS Capital
AXS
$7.3B
| $76.5M | 0.01% |
1,522,693
+1,441,816
| +1,783% | +$76.8M |
|
|
KYNB
725
Kyntra Bio
KYNB
$28.5M
| $76.4M | 0.01% |
64,445
+10,325
| +19% | +$12.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.